Waltham, MA, United States of America

George Byron Mullen



Average Co-Inventor Count = 4.4

ph-index = 4

Forward Citations = 37(Granted Patents)


Location History:

  • Milford, MA (US) (2006 - 2007)
  • Waltham, MA (US) (2004 - 2010)
  • Wilmington, NC (US) (2013)

Company Filing History:


Years Active: 2004-2013

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: George Byron Mullen: Innovator in Antibacterial Research

Introduction

George Byron Mullen is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of antibacterial compounds. With a total of 5 patents, Mullen's work focuses on innovative solutions to combat bacterial infections.

Latest Patents

Mullen's latest patents include groundbreaking research on antibacterial piperdine derivatives. These compounds, described by the formula (I), and their pharmaceutically acceptable salts, are aimed at providing effective treatments for bacterial infections. Additionally, he has developed pyrrol derivatives with antibacterial activity, which also include processes for their preparation and pharmaceutical compositions for use as medicaments.

Career Highlights

Mullen is currently associated with AstraZeneca Ab, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to the advancement of medical treatments that address critical health challenges.

Collaborations

Mullen has collaborated with esteemed colleagues, including Eifion D. Phillips and James T. Loch, III. These partnerships have fostered a collaborative environment that enhances the innovation process in their research endeavors.

Conclusion

George Byron Mullen's contributions to antibacterial research exemplify the importance of innovation in medicine. His patents and ongoing work continue to pave the way for new treatments that can significantly impact public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…